Global Immunoisolation Cell Encapsulation Device Market Growth 2026-2032
The global Immunoisolation Cell Encapsulation Device market size is predicted to grow from US$ 115 million in 2025 to US$ 272 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.
An immunoisolation cell encapsulation device is a cell therapy delivery device that separates therapeutic living cells from the host immune system through semipermeable membranes, microcapsules, hydrogels, or implantable chambers while allowing exchange of oxygen, nutrients, metabolic waste, and therapeutic molecules. It is mainly used for islet cell replacement, sustained secretion from engineered cells, allogeneic or xenogeneic cell transplantation, and preclinical cell therapy evaluation. Product value comes from material biocompatibility, pore-size and mass-transfer control, cell viability maintenance, retrievability, GMP manufacturing, and regulatory validation as a combination product, with an estimated gross margin of about 55%.
Downstream demand is mainly driven by type 1 diabetes cell replacement therapy, allogeneic cell therapy, and engineered cell platforms that can provide long-term secretion of therapeutic proteins. Compared with direct cell infusion, immunoisolation devices can reduce reliance on systemic immunosuppression and provide a more controllable engineered carrier for cell dose, implantation site, and safe retrieval, making them suitable for standardized combination products led by major pharmaceutical and regenerative medicine companies.
Product upgrades are focused on high-throughput mass transfer, anti-fibrotic materials, local immunomodulation, oxygenation design, and prevascularized structures. The supplier landscape is still led by European and North American innovation companies and translational medicine teams, with limited commercialized products. Companies typically build barriers through proprietary materials, device architecture, cell source know-how, and clinical data, and future scale-up is more likely to occur through pharmaceutical partnerships, licensing, or acquisitions.
Key opportunities come from diabetes, endocrine replacement, sustained protein/enzyme delivery, and localized cancer cell therapy, but risks remain high, including foreign body response, hypoxia, batch consistency, implantation workflow, long-term follow-up, and combination-product regulatory requirements. Suppliers with GMP manufacturing, retrievable device design, and integrated cell-material validation capabilities are better positioned to enter clinical programs.
LP Information, Inc. (LPI) ' newest research report, the “Immunoisolation Cell Encapsulation Device Industry Forecast” looks at past sales and reviews total world Immunoisolation Cell Encapsulation Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Immunoisolation Cell Encapsulation Device sales for 2026 through 2032. With Immunoisolation Cell Encapsulation Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunoisolation Cell Encapsulation Device industry.
This Insight Report provides a comprehensive analysis of the global Immunoisolation Cell Encapsulation Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunoisolation Cell Encapsulation Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunoisolation Cell Encapsulation Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunoisolation Cell Encapsulation Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunoisolation Cell Encapsulation Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunoisolation Cell Encapsulation Device market by product type, application, key manufacturers and key regions and countries.
An immunoisolation cell encapsulation device is a cell therapy delivery device that separates therapeutic living cells from the host immune system through semipermeable membranes, microcapsules, hydrogels, or implantable chambers while allowing exchange of oxygen, nutrients, metabolic waste, and therapeutic molecules. It is mainly used for islet cell replacement, sustained secretion from engineered cells, allogeneic or xenogeneic cell transplantation, and preclinical cell therapy evaluation. Product value comes from material biocompatibility, pore-size and mass-transfer control, cell viability maintenance, retrievability, GMP manufacturing, and regulatory validation as a combination product, with an estimated gross margin of about 55%.
Downstream demand is mainly driven by type 1 diabetes cell replacement therapy, allogeneic cell therapy, and engineered cell platforms that can provide long-term secretion of therapeutic proteins. Compared with direct cell infusion, immunoisolation devices can reduce reliance on systemic immunosuppression and provide a more controllable engineered carrier for cell dose, implantation site, and safe retrieval, making them suitable for standardized combination products led by major pharmaceutical and regenerative medicine companies.
Product upgrades are focused on high-throughput mass transfer, anti-fibrotic materials, local immunomodulation, oxygenation design, and prevascularized structures. The supplier landscape is still led by European and North American innovation companies and translational medicine teams, with limited commercialized products. Companies typically build barriers through proprietary materials, device architecture, cell source know-how, and clinical data, and future scale-up is more likely to occur through pharmaceutical partnerships, licensing, or acquisitions.
Key opportunities come from diabetes, endocrine replacement, sustained protein/enzyme delivery, and localized cancer cell therapy, but risks remain high, including foreign body response, hypoxia, batch consistency, implantation workflow, long-term follow-up, and combination-product regulatory requirements. Suppliers with GMP manufacturing, retrievable device design, and integrated cell-material validation capabilities are better positioned to enter clinical programs.
LP Information, Inc. (LPI) ' newest research report, the “Immunoisolation Cell Encapsulation Device Industry Forecast” looks at past sales and reviews total world Immunoisolation Cell Encapsulation Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Immunoisolation Cell Encapsulation Device sales for 2026 through 2032. With Immunoisolation Cell Encapsulation Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunoisolation Cell Encapsulation Device industry.
This Insight Report provides a comprehensive analysis of the global Immunoisolation Cell Encapsulation Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunoisolation Cell Encapsulation Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunoisolation Cell Encapsulation Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunoisolation Cell Encapsulation Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunoisolation Cell Encapsulation Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunoisolation Cell Encapsulation Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Microcapsule Encapsulation Devices
- Sheet and Pouch Macroencapsulation Devices
- Hollow-Fiber Encapsulation Devices
- Chamber Encapsulation Devices
- Conformal Coating Encapsulation Devices
Segmentation by Immunoisolation Mechanism:
- Size-Selective Semipermeable Membrane
- Hydrogel Matrix Barrier
- Cellulose Sulfate Polymer Capsule
- Local Immunomodulation Barrier
- Nanoporous Membrane Barrier
Segmentation by Cell Source:
- Human Donor Islets
- Stem Cell-Derived Islet Cells
- Porcine Islet Cells
- Engineered Therapeutic Cells
- Stem Cells and Stromal Cells
- Other Therapeutic Cells
Segmentation by Oxygenation and Vascularization Design:
- Passive Diffusion Design
- Prevascularized Design
- Oxygen-Refueled Design
- Oxygen-Generating Design
- Port-Accessible Refillable Design
Segmentation by Application:
- Type 1 Diabetes Cell Therapy
- Metabolic and Endocrine Replacement
- Protein and Enzyme Delivery
- Cancer Local Cell Therapy
- Cell Therapy R&D and Preclinical Evaluation
- Bioreactor Cell Protection
- Other Applications
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Vertex Pharmaceuticals
- Sernova
- Defymed
- TheraCyte
- Austrianova
- Diatranz Otsuka
- Otsuka Pharmaceutical Factory
- Procyon Technologies
- Novo Nordisk
- Eli Lilly
- PharmaCyte Biotech
- Beta-O2 Technologies
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Immunoisolation Cell Encapsulation Device market?
- What factors are driving Immunoisolation Cell Encapsulation Device market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Immunoisolation Cell Encapsulation Device market opportunities vary by end market size?
- How does Immunoisolation Cell Encapsulation Device break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunoisolation Cell Encapsulation Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Immunoisolation Cell Encapsulation Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Immunoisolation Cell Encapsulation Device by Country/Region, 2021, 2025 & 2032
2.2 Immunoisolation Cell Encapsulation Device Segment by Type
2.2.1 Microcapsule Encapsulation Devices
2.2.2 Sheet and Pouch Macroencapsulation Devices
2.2.3 Hollow-Fiber Encapsulation Devices
2.2.4 Chamber Encapsulation Devices
2.2.5 Conformal Coating Encapsulation Devices
2.2.6 Immunoisolation Cell Encapsulation Device Sales by Type
2.2.6.1 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
2.2.6.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Type (2021-2026)
2.3 Immunoisolation Cell Encapsulation Device Segment by Immunoisolation Mechanism
2.3.1 Size-Selective Semipermeable Membrane
2.3.2 Hydrogel Matrix Barrier
2.3.3 Cellulose Sulfate Polymer Capsule
2.3.4 Local Immunomodulation Barrier
2.3.5 Nanoporous Membrane Barrier
2.3.6 Immunoisolation Cell Encapsulation Device Sales by Immunoisolation Mechanism
2.3.6.1 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Immunoisolation Mechanism (2021-2026)
2.3.6.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Immunoisolation Mechanism (2021-2026)
2.3.6.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Immunoisolation Mechanism (2021-2026)
2.4 Immunoisolation Cell Encapsulation Device Segment by Cell Source
2.4.1 Human Donor Islets
2.4.2 Stem Cell-Derived Islet Cells
2.4.3 Porcine Islet Cells
2.4.4 Engineered Therapeutic Cells
2.4.5 Stem Cells and Stromal Cells
2.4.6 Other Therapeutic Cells
2.4.7 Immunoisolation Cell Encapsulation Device Sales by Cell Source
2.4.7.1 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Cell Source (2021-2026)
2.4.7.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Cell Source (2021-2026)
2.4.7.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Cell Source (2021-2026)
2.5 Immunoisolation Cell Encapsulation Device Segment by Oxygenation and Vascularization Design
2.5.1 Passive Diffusion Design
2.5.2 Prevascularized Design
2.5.3 Oxygen-Refueled Design
2.5.4 Oxygen-Generating Design
2.5.5 Port-Accessible Refillable Design
2.5.6 Immunoisolation Cell Encapsulation Device Sales by Oxygenation and Vascularization Design
2.5.6.1 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Oxygenation and Vascularization Design (2021-2026)
2.5.6.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Oxygenation and Vascularization Design (2021-2026)
2.5.6.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Oxygenation and Vascularization Design (2021-2026)
2.6 Immunoisolation Cell Encapsulation Device Segment by Application
2.6.1 Type 1 Diabetes Cell Therapy
2.6.2 Metabolic and Endocrine Replacement
2.6.3 Protein and Enzyme Delivery
2.6.4 Cancer Local Cell Therapy
2.6.5 Cell Therapy R&D and Preclinical Evaluation
2.6.6 Bioreactor Cell Protection
2.6.7 Other Applications
2.6.8 Immunoisolation Cell Encapsulation Device Sales by Application
2.6.8.1 Global Immunoisolation Cell Encapsulation Device Sale Market Share by Application (2021-2026)
2.6.8.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Application (2021-2026)
2.6.8.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Immunoisolation Cell Encapsulation Device Breakdown Data by Company
3.1.1 Global Immunoisolation Cell Encapsulation Device Annual Sales by Company (2021-2026)
3.1.2 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Company (2021-2026)
3.2 Global Immunoisolation Cell Encapsulation Device Annual Revenue by Company (2021-2026)
3.2.1 Global Immunoisolation Cell Encapsulation Device Revenue by Company (2021-2026)
3.2.2 Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Company (2021-2026)
3.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Company
3.4 Key Manufacturers Immunoisolation Cell Encapsulation Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immunoisolation Cell Encapsulation Device Product Location Distribution
3.4.2 Players Immunoisolation Cell Encapsulation Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMMUNOISOLATION CELL ENCAPSULATION DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Immunoisolation Cell Encapsulation Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Immunoisolation Cell Encapsulation Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Immunoisolation Cell Encapsulation Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Immunoisolation Cell Encapsulation Device Market Size by Country/Region (2021-2026)
4.2.1 Global Immunoisolation Cell Encapsulation Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Immunoisolation Cell Encapsulation Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immunoisolation Cell Encapsulation Device Sales Growth
4.4 APAC Immunoisolation Cell Encapsulation Device Sales Growth
4.5 Europe Immunoisolation Cell Encapsulation Device Sales Growth
4.6 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Growth
5 AMERICAS
5.1 Americas Immunoisolation Cell Encapsulation Device Sales by Country
5.1.1 Americas Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026)
5.1.2 Americas Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026)
5.2 Americas Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026)
5.3 Americas Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunoisolation Cell Encapsulation Device Sales by Region
6.1.1 APAC Immunoisolation Cell Encapsulation Device Sales by Region (2021-2026)
6.1.2 APAC Immunoisolation Cell Encapsulation Device Revenue by Region (2021-2026)
6.2 APAC Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026)
6.3 APAC Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immunoisolation Cell Encapsulation Device by Country
7.1.1 Europe Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026)
7.1.2 Europe Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026)
7.2 Europe Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026)
7.3 Europe Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunoisolation Cell Encapsulation Device by Country
8.1.1 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026)
8.3 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immunoisolation Cell Encapsulation Device
10.3 Manufacturing Process Analysis of Immunoisolation Cell Encapsulation Device
10.4 Industry Chain Structure of Immunoisolation Cell Encapsulation Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immunoisolation Cell Encapsulation Device Distributors
11.3 Immunoisolation Cell Encapsulation Device Customer
12 WORLD FORECAST REVIEW FOR IMMUNOISOLATION CELL ENCAPSULATION DEVICE BY GEOGRAPHIC REGION
12.1 Global Immunoisolation Cell Encapsulation Device Market Size Forecast by Region
12.1.1 Global Immunoisolation Cell Encapsulation Device Forecast by Region (2027-2032)
12.1.2 Global Immunoisolation Cell Encapsulation Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Immunoisolation Cell Encapsulation Device Forecast by Type (2027-2032)
12.7 Global Immunoisolation Cell Encapsulation Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Vertex Pharmaceuticals
13.1.1 Vertex Pharmaceuticals Company Information
13.1.2 Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.1.3 Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Vertex Pharmaceuticals Main Business Overview
13.1.5 Vertex Pharmaceuticals Latest Developments
13.2 Sernova
13.2.1 Sernova Company Information
13.2.2 Sernova Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.2.3 Sernova Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sernova Main Business Overview
13.2.5 Sernova Latest Developments
13.3 Defymed
13.3.1 Defymed Company Information
13.3.2 Defymed Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.3.3 Defymed Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Defymed Main Business Overview
13.3.5 Defymed Latest Developments
13.4 TheraCyte
13.4.1 TheraCyte Company Information
13.4.2 TheraCyte Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.4.3 TheraCyte Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 TheraCyte Main Business Overview
13.4.5 TheraCyte Latest Developments
13.5 Austrianova
13.5.1 Austrianova Company Information
13.5.2 Austrianova Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.5.3 Austrianova Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Austrianova Main Business Overview
13.5.5 Austrianova Latest Developments
13.6 Diatranz Otsuka
13.6.1 Diatranz Otsuka Company Information
13.6.2 Diatranz Otsuka Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.6.3 Diatranz Otsuka Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Diatranz Otsuka Main Business Overview
13.6.5 Diatranz Otsuka Latest Developments
13.7 Otsuka Pharmaceutical Factory
13.7.1 Otsuka Pharmaceutical Factory Company Information
13.7.2 Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.7.3 Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Otsuka Pharmaceutical Factory Main Business Overview
13.7.5 Otsuka Pharmaceutical Factory Latest Developments
13.8 Procyon Technologies
13.8.1 Procyon Technologies Company Information
13.8.2 Procyon Technologies Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.8.3 Procyon Technologies Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Procyon Technologies Main Business Overview
13.8.5 Procyon Technologies Latest Developments
13.9 Novo Nordisk
13.9.1 Novo Nordisk Company Information
13.9.2 Novo Nordisk Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.9.3 Novo Nordisk Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Novo Nordisk Main Business Overview
13.9.5 Novo Nordisk Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.10.3 Eli Lilly Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 PharmaCyte Biotech
13.11.1 PharmaCyte Biotech Company Information
13.11.2 PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.11.3 PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 PharmaCyte Biotech Main Business Overview
13.11.5 PharmaCyte Biotech Latest Developments
13.12 Beta-O2 Technologies
13.12.1 Beta-O2 Technologies Company Information
13.12.2 Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.12.3 Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beta-O2 Technologies Main Business Overview
13.12.5 Beta-O2 Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immunoisolation Cell Encapsulation Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Immunoisolation Cell Encapsulation Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Immunoisolation Cell Encapsulation Device by Country/Region, 2021, 2025 & 2032
2.2 Immunoisolation Cell Encapsulation Device Segment by Type
2.2.1 Microcapsule Encapsulation Devices
2.2.2 Sheet and Pouch Macroencapsulation Devices
2.2.3 Hollow-Fiber Encapsulation Devices
2.2.4 Chamber Encapsulation Devices
2.2.5 Conformal Coating Encapsulation Devices
2.2.6 Immunoisolation Cell Encapsulation Device Sales by Type
2.2.6.1 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
2.2.6.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Type (2021-2026)
2.3 Immunoisolation Cell Encapsulation Device Segment by Immunoisolation Mechanism
2.3.1 Size-Selective Semipermeable Membrane
2.3.2 Hydrogel Matrix Barrier
2.3.3 Cellulose Sulfate Polymer Capsule
2.3.4 Local Immunomodulation Barrier
2.3.5 Nanoporous Membrane Barrier
2.3.6 Immunoisolation Cell Encapsulation Device Sales by Immunoisolation Mechanism
2.3.6.1 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Immunoisolation Mechanism (2021-2026)
2.3.6.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Immunoisolation Mechanism (2021-2026)
2.3.6.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Immunoisolation Mechanism (2021-2026)
2.4 Immunoisolation Cell Encapsulation Device Segment by Cell Source
2.4.1 Human Donor Islets
2.4.2 Stem Cell-Derived Islet Cells
2.4.3 Porcine Islet Cells
2.4.4 Engineered Therapeutic Cells
2.4.5 Stem Cells and Stromal Cells
2.4.6 Other Therapeutic Cells
2.4.7 Immunoisolation Cell Encapsulation Device Sales by Cell Source
2.4.7.1 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Cell Source (2021-2026)
2.4.7.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Cell Source (2021-2026)
2.4.7.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Cell Source (2021-2026)
2.5 Immunoisolation Cell Encapsulation Device Segment by Oxygenation and Vascularization Design
2.5.1 Passive Diffusion Design
2.5.2 Prevascularized Design
2.5.3 Oxygen-Refueled Design
2.5.4 Oxygen-Generating Design
2.5.5 Port-Accessible Refillable Design
2.5.6 Immunoisolation Cell Encapsulation Device Sales by Oxygenation and Vascularization Design
2.5.6.1 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Oxygenation and Vascularization Design (2021-2026)
2.5.6.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Oxygenation and Vascularization Design (2021-2026)
2.5.6.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Oxygenation and Vascularization Design (2021-2026)
2.6 Immunoisolation Cell Encapsulation Device Segment by Application
2.6.1 Type 1 Diabetes Cell Therapy
2.6.2 Metabolic and Endocrine Replacement
2.6.3 Protein and Enzyme Delivery
2.6.4 Cancer Local Cell Therapy
2.6.5 Cell Therapy R&D and Preclinical Evaluation
2.6.6 Bioreactor Cell Protection
2.6.7 Other Applications
2.6.8 Immunoisolation Cell Encapsulation Device Sales by Application
2.6.8.1 Global Immunoisolation Cell Encapsulation Device Sale Market Share by Application (2021-2026)
2.6.8.2 Global Immunoisolation Cell Encapsulation Device Revenue and Market Share by Application (2021-2026)
2.6.8.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Immunoisolation Cell Encapsulation Device Breakdown Data by Company
3.1.1 Global Immunoisolation Cell Encapsulation Device Annual Sales by Company (2021-2026)
3.1.2 Global Immunoisolation Cell Encapsulation Device Sales Market Share by Company (2021-2026)
3.2 Global Immunoisolation Cell Encapsulation Device Annual Revenue by Company (2021-2026)
3.2.1 Global Immunoisolation Cell Encapsulation Device Revenue by Company (2021-2026)
3.2.2 Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Company (2021-2026)
3.3 Global Immunoisolation Cell Encapsulation Device Sale Price by Company
3.4 Key Manufacturers Immunoisolation Cell Encapsulation Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immunoisolation Cell Encapsulation Device Product Location Distribution
3.4.2 Players Immunoisolation Cell Encapsulation Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMMUNOISOLATION CELL ENCAPSULATION DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Immunoisolation Cell Encapsulation Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Immunoisolation Cell Encapsulation Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Immunoisolation Cell Encapsulation Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Immunoisolation Cell Encapsulation Device Market Size by Country/Region (2021-2026)
4.2.1 Global Immunoisolation Cell Encapsulation Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Immunoisolation Cell Encapsulation Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immunoisolation Cell Encapsulation Device Sales Growth
4.4 APAC Immunoisolation Cell Encapsulation Device Sales Growth
4.5 Europe Immunoisolation Cell Encapsulation Device Sales Growth
4.6 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Growth
5 AMERICAS
5.1 Americas Immunoisolation Cell Encapsulation Device Sales by Country
5.1.1 Americas Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026)
5.1.2 Americas Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026)
5.2 Americas Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026)
5.3 Americas Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immunoisolation Cell Encapsulation Device Sales by Region
6.1.1 APAC Immunoisolation Cell Encapsulation Device Sales by Region (2021-2026)
6.1.2 APAC Immunoisolation Cell Encapsulation Device Revenue by Region (2021-2026)
6.2 APAC Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026)
6.3 APAC Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immunoisolation Cell Encapsulation Device by Country
7.1.1 Europe Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026)
7.1.2 Europe Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026)
7.2 Europe Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026)
7.3 Europe Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immunoisolation Cell Encapsulation Device by Country
8.1.1 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026)
8.3 Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immunoisolation Cell Encapsulation Device
10.3 Manufacturing Process Analysis of Immunoisolation Cell Encapsulation Device
10.4 Industry Chain Structure of Immunoisolation Cell Encapsulation Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immunoisolation Cell Encapsulation Device Distributors
11.3 Immunoisolation Cell Encapsulation Device Customer
12 WORLD FORECAST REVIEW FOR IMMUNOISOLATION CELL ENCAPSULATION DEVICE BY GEOGRAPHIC REGION
12.1 Global Immunoisolation Cell Encapsulation Device Market Size Forecast by Region
12.1.1 Global Immunoisolation Cell Encapsulation Device Forecast by Region (2027-2032)
12.1.2 Global Immunoisolation Cell Encapsulation Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Immunoisolation Cell Encapsulation Device Forecast by Type (2027-2032)
12.7 Global Immunoisolation Cell Encapsulation Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Vertex Pharmaceuticals
13.1.1 Vertex Pharmaceuticals Company Information
13.1.2 Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.1.3 Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Vertex Pharmaceuticals Main Business Overview
13.1.5 Vertex Pharmaceuticals Latest Developments
13.2 Sernova
13.2.1 Sernova Company Information
13.2.2 Sernova Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.2.3 Sernova Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sernova Main Business Overview
13.2.5 Sernova Latest Developments
13.3 Defymed
13.3.1 Defymed Company Information
13.3.2 Defymed Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.3.3 Defymed Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Defymed Main Business Overview
13.3.5 Defymed Latest Developments
13.4 TheraCyte
13.4.1 TheraCyte Company Information
13.4.2 TheraCyte Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.4.3 TheraCyte Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 TheraCyte Main Business Overview
13.4.5 TheraCyte Latest Developments
13.5 Austrianova
13.5.1 Austrianova Company Information
13.5.2 Austrianova Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.5.3 Austrianova Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Austrianova Main Business Overview
13.5.5 Austrianova Latest Developments
13.6 Diatranz Otsuka
13.6.1 Diatranz Otsuka Company Information
13.6.2 Diatranz Otsuka Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.6.3 Diatranz Otsuka Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Diatranz Otsuka Main Business Overview
13.6.5 Diatranz Otsuka Latest Developments
13.7 Otsuka Pharmaceutical Factory
13.7.1 Otsuka Pharmaceutical Factory Company Information
13.7.2 Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.7.3 Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Otsuka Pharmaceutical Factory Main Business Overview
13.7.5 Otsuka Pharmaceutical Factory Latest Developments
13.8 Procyon Technologies
13.8.1 Procyon Technologies Company Information
13.8.2 Procyon Technologies Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.8.3 Procyon Technologies Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Procyon Technologies Main Business Overview
13.8.5 Procyon Technologies Latest Developments
13.9 Novo Nordisk
13.9.1 Novo Nordisk Company Information
13.9.2 Novo Nordisk Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.9.3 Novo Nordisk Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Novo Nordisk Main Business Overview
13.9.5 Novo Nordisk Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.10.3 Eli Lilly Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 PharmaCyte Biotech
13.11.1 PharmaCyte Biotech Company Information
13.11.2 PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.11.3 PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 PharmaCyte Biotech Main Business Overview
13.11.5 PharmaCyte Biotech Latest Developments
13.12 Beta-O2 Technologies
13.12.1 Beta-O2 Technologies Company Information
13.12.2 Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
13.12.3 Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beta-O2 Technologies Main Business Overview
13.12.5 Beta-O2 Technologies Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immunoisolation Cell Encapsulation Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Immunoisolation Cell Encapsulation Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Microcapsule Encapsulation Devices
Table 4. Major Players of Sheet and Pouch Macroencapsulation Devices
Table 5. Major Players of Hollow-Fiber Encapsulation Devices
Table 6. Major Players of Chamber Encapsulation Devices
Table 7. Major Players of Conformal Coating Encapsulation Devices
Table 8. Global Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 9. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Table 10. Global Immunoisolation Cell Encapsulation Device Revenue by Type (2021-2026) & ($ million)
Table 11. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Type (2021-2026)
Table 12. Global Immunoisolation Cell Encapsulation Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Major Players of Size-Selective Semipermeable Membrane
Table 14. Major Players of Hydrogel Matrix Barrier
Table 15. Major Players of Cellulose Sulfate Polymer Capsule
Table 16. Major Players of Local Immunomodulation Barrier
Table 17. Major Players of Nanoporous Membrane Barrier
Table 18. Global Immunoisolation Cell Encapsulation Device Sales by Immunoisolation Mechanism (2021-2026) & (Units)
Table 19. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Immunoisolation Mechanism (2021-2026)
Table 20. Global Immunoisolation Cell Encapsulation Device Revenue by Immunoisolation Mechanism (2021-2026) & ($ million)
Table 21. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Immunoisolation Mechanism (2021-2026)
Table 22. Global Immunoisolation Cell Encapsulation Device Sale Price by Immunoisolation Mechanism (2021-2026) & (US$/Unit)
Table 23. Major Players of Human Donor Islets
Table 24. Major Players of Stem Cell-Derived Islet Cells
Table 25. Major Players of Porcine Islet Cells
Table 26. Major Players of Engineered Therapeutic Cells
Table 27. Major Players of Stem Cells and Stromal Cells
Table 28. Major Players of Other Therapeutic Cells
Table 29. Global Immunoisolation Cell Encapsulation Device Sales by Cell Source (2021-2026) & (Units)
Table 30. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Cell Source (2021-2026)
Table 31. Global Immunoisolation Cell Encapsulation Device Revenue by Cell Source (2021-2026) & ($ million)
Table 32. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Cell Source (2021-2026)
Table 33. Global Immunoisolation Cell Encapsulation Device Sale Price by Cell Source (2021-2026) & (US$/Unit)
Table 34. Major Players of Passive Diffusion Design
Table 35. Major Players of Prevascularized Design
Table 36. Major Players of Oxygen-Refueled Design
Table 37. Major Players of Oxygen-Generating Design
Table 38. Major Players of Port-Accessible Refillable Design
Table 39. Global Immunoisolation Cell Encapsulation Device Sales by Oxygenation and Vascularization Design (2021-2026) & (Units)
Table 40. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Oxygenation and Vascularization Design (2021-2026)
Table 41. Global Immunoisolation Cell Encapsulation Device Revenue by Oxygenation and Vascularization Design (2021-2026) & ($ million)
Table 42. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Oxygenation and Vascularization Design (2021-2026)
Table 43. Global Immunoisolation Cell Encapsulation Device Sale Price by Oxygenation and Vascularization Design (2021-2026) & (US$/Unit)
Table 44. Global Immunoisolation Cell Encapsulation Device Sale by Application (2021-2026) & (Units)
Table 45. Global Immunoisolation Cell Encapsulation Device Sale Market Share by Application (2021-2026)
Table 46. Global Immunoisolation Cell Encapsulation Device Revenue by Application (2021-2026) & ($ million)
Table 47. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Application (2021-2026)
Table 48. Global Immunoisolation Cell Encapsulation Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 49. Global Immunoisolation Cell Encapsulation Device Sales by Company (2021-2026) & (Units)
Table 50. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Company (2021-2026)
Table 51. Global Immunoisolation Cell Encapsulation Device Revenue by Company (2021-2026) & ($ millions)
Table 52. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Company (2021-2026)
Table 53. Global Immunoisolation Cell Encapsulation Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 54. Key Manufacturers Immunoisolation Cell Encapsulation Device Producing Area Distribution and Sales Area
Table 55. Players Immunoisolation Cell Encapsulation Device Products Offered
Table 56. Immunoisolation Cell Encapsulation Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 57. New Products and Potential Entrants
Table 58. Market M&A Activity & Strategy
Table 59. Global Immunoisolation Cell Encapsulation Device Sales by Geographic Region (2021-2026) & (Units)
Table 60. Global Immunoisolation Cell Encapsulation Device Sales Market Share Geographic Region (2021-2026)
Table 61. Global Immunoisolation Cell Encapsulation Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 62. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Geographic Region (2021-2026)
Table 63. Global Immunoisolation Cell Encapsulation Device Sales by Country/Region (2021-2026) & (Units)
Table 64. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Country/Region (2021-2026)
Table 65. Global Immunoisolation Cell Encapsulation Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 66. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Country/Region (2021-2026)
Table 67. Americas Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026) & (Units)
Table 68. Americas Immunoisolation Cell Encapsulation Device Sales Market Share by Country (2021-2026)
Table 69. Americas Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026) & ($ millions)
Table 70. Americas Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 71. Americas Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026) & (Units)
Table 72. APAC Immunoisolation Cell Encapsulation Device Sales by Region (2021-2026) & (Units)
Table 73. APAC Immunoisolation Cell Encapsulation Device Sales Market Share by Region (2021-2026)
Table 74. APAC Immunoisolation Cell Encapsulation Device Revenue by Region (2021-2026) & ($ millions)
Table 75. APAC Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 76. APAC Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026) & (Units)
Table 77. Europe Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026) & (Units)
Table 78. Europe Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026) & ($ millions)
Table 79. Europe Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 80. Europe Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026) & (Units)
Table 81. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026) & (Units)
Table 82. Middle East & Africa Immunoisolation Cell Encapsulation Device Revenue Market Share by Country (2021-2026)
Table 83. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 84. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026) & (Units)
Table 85. Key Market Drivers & Growth Opportunities of Immunoisolation Cell Encapsulation Device
Table 86. Key Market Challenges & Risks of Immunoisolation Cell Encapsulation Device
Table 87. Key Industry Trends of Immunoisolation Cell Encapsulation Device
Table 88. Immunoisolation Cell Encapsulation Device Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Immunoisolation Cell Encapsulation Device Distributors List
Table 91. Immunoisolation Cell Encapsulation Device Customer List
Table 92. Global Immunoisolation Cell Encapsulation Device Sales Forecast by Region (2027-2032) & (Units)
Table 93. Global Immunoisolation Cell Encapsulation Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 94. Americas Immunoisolation Cell Encapsulation Device Sales Forecast by Country (2027-2032) & (Units)
Table 95. Americas Immunoisolation Cell Encapsulation Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 96. APAC Immunoisolation Cell Encapsulation Device Sales Forecast by Region (2027-2032) & (Units)
Table 97. APAC Immunoisolation Cell Encapsulation Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 98. Europe Immunoisolation Cell Encapsulation Device Sales Forecast by Country (2027-2032) & (Units)
Table 99. Europe Immunoisolation Cell Encapsulation Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 100. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Forecast by Country (2027-2032) & (Units)
Table 101. Middle East & Africa Immunoisolation Cell Encapsulation Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 102. Global Immunoisolation Cell Encapsulation Device Sales Forecast by Type (2027-2032) & (Units)
Table 103. Global Immunoisolation Cell Encapsulation Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 104. Global Immunoisolation Cell Encapsulation Device Sales Forecast by Application (2027-2032) & (Units)
Table 105. Global Immunoisolation Cell Encapsulation Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 106. Vertex Pharmaceuticals Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 107. Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 108. Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Vertex Pharmaceuticals Main Business
Table 110. Vertex Pharmaceuticals Latest Developments
Table 111. Sernova Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 112. Sernova Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 113. Sernova Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Sernova Main Business
Table 115. Sernova Latest Developments
Table 116. Defymed Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 117. Defymed Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 118. Defymed Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Defymed Main Business
Table 120. Defymed Latest Developments
Table 121. TheraCyte Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 122. TheraCyte Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 123. TheraCyte Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. TheraCyte Main Business
Table 125. TheraCyte Latest Developments
Table 126. Austrianova Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 127. Austrianova Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 128. Austrianova Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Austrianova Main Business
Table 130. Austrianova Latest Developments
Table 131. Diatranz Otsuka Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 132. Diatranz Otsuka Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 133. Diatranz Otsuka Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Diatranz Otsuka Main Business
Table 135. Diatranz Otsuka Latest Developments
Table 136. Otsuka Pharmaceutical Factory Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 137. Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 138. Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Otsuka Pharmaceutical Factory Main Business
Table 140. Otsuka Pharmaceutical Factory Latest Developments
Table 141. Procyon Technologies Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 142. Procyon Technologies Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 143. Procyon Technologies Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Procyon Technologies Main Business
Table 145. Procyon Technologies Latest Developments
Table 146. Novo Nordisk Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 147. Novo Nordisk Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 148. Novo Nordisk Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. Novo Nordisk Main Business
Table 150. Novo Nordisk Latest Developments
Table 151. Eli Lilly Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 152. Eli Lilly Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 153. Eli Lilly Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Eli Lilly Main Business
Table 155. Eli Lilly Latest Developments
Table 156. PharmaCyte Biotech Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 157. PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 158. PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. PharmaCyte Biotech Main Business
Table 160. PharmaCyte Biotech Latest Developments
Table 161. Beta-O2 Technologies Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 162. Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 163. Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Beta-O2 Technologies Main Business
Table 165. Beta-O2 Technologies Latest Developments
Table 1. Immunoisolation Cell Encapsulation Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Immunoisolation Cell Encapsulation Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Microcapsule Encapsulation Devices
Table 4. Major Players of Sheet and Pouch Macroencapsulation Devices
Table 5. Major Players of Hollow-Fiber Encapsulation Devices
Table 6. Major Players of Chamber Encapsulation Devices
Table 7. Major Players of Conformal Coating Encapsulation Devices
Table 8. Global Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 9. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Table 10. Global Immunoisolation Cell Encapsulation Device Revenue by Type (2021-2026) & ($ million)
Table 11. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Type (2021-2026)
Table 12. Global Immunoisolation Cell Encapsulation Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Major Players of Size-Selective Semipermeable Membrane
Table 14. Major Players of Hydrogel Matrix Barrier
Table 15. Major Players of Cellulose Sulfate Polymer Capsule
Table 16. Major Players of Local Immunomodulation Barrier
Table 17. Major Players of Nanoporous Membrane Barrier
Table 18. Global Immunoisolation Cell Encapsulation Device Sales by Immunoisolation Mechanism (2021-2026) & (Units)
Table 19. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Immunoisolation Mechanism (2021-2026)
Table 20. Global Immunoisolation Cell Encapsulation Device Revenue by Immunoisolation Mechanism (2021-2026) & ($ million)
Table 21. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Immunoisolation Mechanism (2021-2026)
Table 22. Global Immunoisolation Cell Encapsulation Device Sale Price by Immunoisolation Mechanism (2021-2026) & (US$/Unit)
Table 23. Major Players of Human Donor Islets
Table 24. Major Players of Stem Cell-Derived Islet Cells
Table 25. Major Players of Porcine Islet Cells
Table 26. Major Players of Engineered Therapeutic Cells
Table 27. Major Players of Stem Cells and Stromal Cells
Table 28. Major Players of Other Therapeutic Cells
Table 29. Global Immunoisolation Cell Encapsulation Device Sales by Cell Source (2021-2026) & (Units)
Table 30. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Cell Source (2021-2026)
Table 31. Global Immunoisolation Cell Encapsulation Device Revenue by Cell Source (2021-2026) & ($ million)
Table 32. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Cell Source (2021-2026)
Table 33. Global Immunoisolation Cell Encapsulation Device Sale Price by Cell Source (2021-2026) & (US$/Unit)
Table 34. Major Players of Passive Diffusion Design
Table 35. Major Players of Prevascularized Design
Table 36. Major Players of Oxygen-Refueled Design
Table 37. Major Players of Oxygen-Generating Design
Table 38. Major Players of Port-Accessible Refillable Design
Table 39. Global Immunoisolation Cell Encapsulation Device Sales by Oxygenation and Vascularization Design (2021-2026) & (Units)
Table 40. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Oxygenation and Vascularization Design (2021-2026)
Table 41. Global Immunoisolation Cell Encapsulation Device Revenue by Oxygenation and Vascularization Design (2021-2026) & ($ million)
Table 42. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Oxygenation and Vascularization Design (2021-2026)
Table 43. Global Immunoisolation Cell Encapsulation Device Sale Price by Oxygenation and Vascularization Design (2021-2026) & (US$/Unit)
Table 44. Global Immunoisolation Cell Encapsulation Device Sale by Application (2021-2026) & (Units)
Table 45. Global Immunoisolation Cell Encapsulation Device Sale Market Share by Application (2021-2026)
Table 46. Global Immunoisolation Cell Encapsulation Device Revenue by Application (2021-2026) & ($ million)
Table 47. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Application (2021-2026)
Table 48. Global Immunoisolation Cell Encapsulation Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 49. Global Immunoisolation Cell Encapsulation Device Sales by Company (2021-2026) & (Units)
Table 50. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Company (2021-2026)
Table 51. Global Immunoisolation Cell Encapsulation Device Revenue by Company (2021-2026) & ($ millions)
Table 52. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Company (2021-2026)
Table 53. Global Immunoisolation Cell Encapsulation Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 54. Key Manufacturers Immunoisolation Cell Encapsulation Device Producing Area Distribution and Sales Area
Table 55. Players Immunoisolation Cell Encapsulation Device Products Offered
Table 56. Immunoisolation Cell Encapsulation Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 57. New Products and Potential Entrants
Table 58. Market M&A Activity & Strategy
Table 59. Global Immunoisolation Cell Encapsulation Device Sales by Geographic Region (2021-2026) & (Units)
Table 60. Global Immunoisolation Cell Encapsulation Device Sales Market Share Geographic Region (2021-2026)
Table 61. Global Immunoisolation Cell Encapsulation Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 62. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Geographic Region (2021-2026)
Table 63. Global Immunoisolation Cell Encapsulation Device Sales by Country/Region (2021-2026) & (Units)
Table 64. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Country/Region (2021-2026)
Table 65. Global Immunoisolation Cell Encapsulation Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 66. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Country/Region (2021-2026)
Table 67. Americas Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026) & (Units)
Table 68. Americas Immunoisolation Cell Encapsulation Device Sales Market Share by Country (2021-2026)
Table 69. Americas Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026) & ($ millions)
Table 70. Americas Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 71. Americas Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026) & (Units)
Table 72. APAC Immunoisolation Cell Encapsulation Device Sales by Region (2021-2026) & (Units)
Table 73. APAC Immunoisolation Cell Encapsulation Device Sales Market Share by Region (2021-2026)
Table 74. APAC Immunoisolation Cell Encapsulation Device Revenue by Region (2021-2026) & ($ millions)
Table 75. APAC Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 76. APAC Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026) & (Units)
Table 77. Europe Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026) & (Units)
Table 78. Europe Immunoisolation Cell Encapsulation Device Revenue by Country (2021-2026) & ($ millions)
Table 79. Europe Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 80. Europe Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026) & (Units)
Table 81. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Country (2021-2026) & (Units)
Table 82. Middle East & Africa Immunoisolation Cell Encapsulation Device Revenue Market Share by Country (2021-2026)
Table 83. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Type (2021-2026) & (Units)
Table 84. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales by Application (2021-2026) & (Units)
Table 85. Key Market Drivers & Growth Opportunities of Immunoisolation Cell Encapsulation Device
Table 86. Key Market Challenges & Risks of Immunoisolation Cell Encapsulation Device
Table 87. Key Industry Trends of Immunoisolation Cell Encapsulation Device
Table 88. Immunoisolation Cell Encapsulation Device Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Immunoisolation Cell Encapsulation Device Distributors List
Table 91. Immunoisolation Cell Encapsulation Device Customer List
Table 92. Global Immunoisolation Cell Encapsulation Device Sales Forecast by Region (2027-2032) & (Units)
Table 93. Global Immunoisolation Cell Encapsulation Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 94. Americas Immunoisolation Cell Encapsulation Device Sales Forecast by Country (2027-2032) & (Units)
Table 95. Americas Immunoisolation Cell Encapsulation Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 96. APAC Immunoisolation Cell Encapsulation Device Sales Forecast by Region (2027-2032) & (Units)
Table 97. APAC Immunoisolation Cell Encapsulation Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 98. Europe Immunoisolation Cell Encapsulation Device Sales Forecast by Country (2027-2032) & (Units)
Table 99. Europe Immunoisolation Cell Encapsulation Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 100. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Forecast by Country (2027-2032) & (Units)
Table 101. Middle East & Africa Immunoisolation Cell Encapsulation Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 102. Global Immunoisolation Cell Encapsulation Device Sales Forecast by Type (2027-2032) & (Units)
Table 103. Global Immunoisolation Cell Encapsulation Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 104. Global Immunoisolation Cell Encapsulation Device Sales Forecast by Application (2027-2032) & (Units)
Table 105. Global Immunoisolation Cell Encapsulation Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 106. Vertex Pharmaceuticals Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 107. Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 108. Vertex Pharmaceuticals Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Vertex Pharmaceuticals Main Business
Table 110. Vertex Pharmaceuticals Latest Developments
Table 111. Sernova Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 112. Sernova Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 113. Sernova Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Sernova Main Business
Table 115. Sernova Latest Developments
Table 116. Defymed Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 117. Defymed Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 118. Defymed Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. Defymed Main Business
Table 120. Defymed Latest Developments
Table 121. TheraCyte Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 122. TheraCyte Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 123. TheraCyte Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. TheraCyte Main Business
Table 125. TheraCyte Latest Developments
Table 126. Austrianova Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 127. Austrianova Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 128. Austrianova Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Austrianova Main Business
Table 130. Austrianova Latest Developments
Table 131. Diatranz Otsuka Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 132. Diatranz Otsuka Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 133. Diatranz Otsuka Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Diatranz Otsuka Main Business
Table 135. Diatranz Otsuka Latest Developments
Table 136. Otsuka Pharmaceutical Factory Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 137. Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 138. Otsuka Pharmaceutical Factory Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Otsuka Pharmaceutical Factory Main Business
Table 140. Otsuka Pharmaceutical Factory Latest Developments
Table 141. Procyon Technologies Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 142. Procyon Technologies Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 143. Procyon Technologies Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Procyon Technologies Main Business
Table 145. Procyon Technologies Latest Developments
Table 146. Novo Nordisk Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 147. Novo Nordisk Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 148. Novo Nordisk Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. Novo Nordisk Main Business
Table 150. Novo Nordisk Latest Developments
Table 151. Eli Lilly Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 152. Eli Lilly Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 153. Eli Lilly Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. Eli Lilly Main Business
Table 155. Eli Lilly Latest Developments
Table 156. PharmaCyte Biotech Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 157. PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 158. PharmaCyte Biotech Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. PharmaCyte Biotech Main Business
Table 160. PharmaCyte Biotech Latest Developments
Table 161. Beta-O2 Technologies Basic Information, Immunoisolation Cell Encapsulation Device Manufacturing Base, Sales Area and Its Competitors
Table 162. Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Product Portfolios and Specifications
Table 163. Beta-O2 Technologies Immunoisolation Cell Encapsulation Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Beta-O2 Technologies Main Business
Table 165. Beta-O2 Technologies Latest Developments
LIST OF FIGURES
Figure 1. Picture of Immunoisolation Cell Encapsulation Device
Figure 2. Immunoisolation Cell Encapsulation Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunoisolation Cell Encapsulation Device Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Immunoisolation Cell Encapsulation Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Immunoisolation Cell Encapsulation Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Immunoisolation Cell Encapsulation Device Sales Market Share by Country/Region (2025)
Figure 10. Immunoisolation Cell Encapsulation Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Microcapsule Encapsulation Devices
Figure 12. Product Picture of Sheet and Pouch Macroencapsulation Devices
Figure 13. Product Picture of Hollow-Fiber Encapsulation Devices
Figure 14. Product Picture of Chamber Encapsulation Devices
Figure 15. Product Picture of Conformal Coating Encapsulation Devices
Figure 16. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Type in 2026
Figure 17. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Size-Selective Semipermeable Membrane
Figure 19. Product Picture of Hydrogel Matrix Barrier
Figure 20. Product Picture of Cellulose Sulfate Polymer Capsule
Figure 21. Product Picture of Local Immunomodulation Barrier
Figure 22. Product Picture of Nanoporous Membrane Barrier
Figure 23. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Immunoisolation Mechanism in 2026
Figure 24. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Immunoisolation Mechanism (2021-2026)
Figure 25. Product Picture of Human Donor Islets
Figure 26. Product Picture of Stem Cell-Derived Islet Cells
Figure 27. Product Picture of Porcine Islet Cells
Figure 28. Product Picture of Engineered Therapeutic Cells
Figure 29. Product Picture of Stem Cells and Stromal Cells
Figure 30. Product Picture of Other Therapeutic Cells
Figure 31. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Cell Source in 2026
Figure 32. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Cell Source (2021-2026)
Figure 33. Product Picture of Passive Diffusion Design
Figure 34. Product Picture of Prevascularized Design
Figure 35. Product Picture of Oxygen-Refueled Design
Figure 36. Product Picture of Oxygen-Generating Design
Figure 37. Product Picture of Port-Accessible Refillable Design
Figure 38. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Oxygenation and Vascularization Design in 2026
Figure 39. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Oxygenation and Vascularization Design (2021-2026)
Figure 40. Immunoisolation Cell Encapsulation Device Consumed in Type 1 Diabetes Cell Therapy
Figure 41. Global Immunoisolation Cell Encapsulation Device Market: Type 1 Diabetes Cell Therapy (2021-2026) & (Units)
Figure 42. Immunoisolation Cell Encapsulation Device Consumed in Metabolic and Endocrine Replacement
Figure 43. Global Immunoisolation Cell Encapsulation Device Market: Metabolic and Endocrine Replacement (2021-2026) & (Units)
Figure 44. Immunoisolation Cell Encapsulation Device Consumed in Protein and Enzyme Delivery
Figure 45. Global Immunoisolation Cell Encapsulation Device Market: Protein and Enzyme Delivery (2021-2026) & (Units)
Figure 46. Immunoisolation Cell Encapsulation Device Consumed in Cancer Local Cell Therapy
Figure 47. Global Immunoisolation Cell Encapsulation Device Market: Cancer Local Cell Therapy (2021-2026) & (Units)
Figure 48. Immunoisolation Cell Encapsulation Device Consumed in Cell Therapy R&D and Preclinical Evaluation
Figure 49. Global Immunoisolation Cell Encapsulation Device Market: Cell Therapy R&D and Preclinical Evaluation (2021-2026) & (Units)
Figure 50. Immunoisolation Cell Encapsulation Device Consumed in Bioreactor Cell Protection
Figure 51. Global Immunoisolation Cell Encapsulation Device Market: Bioreactor Cell Protection (2021-2026) & (Units)
Figure 52. Immunoisolation Cell Encapsulation Device Consumed in Other Applications
Figure 53. Global Immunoisolation Cell Encapsulation Device Market: Other Applications (2021-2026) & (Units)
Figure 54. Global Immunoisolation Cell Encapsulation Device Sale Market Share by Application (2025)
Figure 55. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Application in 2025
Figure 56. Immunoisolation Cell Encapsulation Device Sales by Company in 2025 (Units)
Figure 57. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Company in 2025
Figure 58. Immunoisolation Cell Encapsulation Device Revenue by Company in 2025 ($ millions)
Figure 59. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Company in 2025
Figure 60. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Geographic Region (2021-2026)
Figure 61. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Geographic Region in 2025
Figure 62. Americas Immunoisolation Cell Encapsulation Device Sales 2021-2026 (Units)
Figure 63. Americas Immunoisolation Cell Encapsulation Device Revenue 2021-2026 ($ millions)
Figure 64. APAC Immunoisolation Cell Encapsulation Device Sales 2021-2026 (Units)
Figure 65. APAC Immunoisolation Cell Encapsulation Device Revenue 2021-2026 ($ millions)
Figure 66. Europe Immunoisolation Cell Encapsulation Device Sales 2021-2026 (Units)
Figure 67. Europe Immunoisolation Cell Encapsulation Device Revenue 2021-2026 ($ millions)
Figure 68. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales 2021-2026 (Units)
Figure 69. Middle East & Africa Immunoisolation Cell Encapsulation Device Revenue 2021-2026 ($ millions)
Figure 70. Americas Immunoisolation Cell Encapsulation Device Sales Market Share by Country in 2025
Figure 71. Americas Immunoisolation Cell Encapsulation Device Revenue Market Share by Country (2021-2026)
Figure 72. Americas Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Figure 73. Americas Immunoisolation Cell Encapsulation Device Sales Market Share by Application (2021-2026)
Figure 74. United States Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 75. Canada Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 76. Mexico Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 77. Brazil Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 78. APAC Immunoisolation Cell Encapsulation Device Sales Market Share by Region in 2025
Figure 79. APAC Immunoisolation Cell Encapsulation Device Revenue Market Share by Region (2021-2026)
Figure 80. APAC Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Figure 81. APAC Immunoisolation Cell Encapsulation Device Sales Market Share by Application (2021-2026)
Figure 82. China Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 83. Japan Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 84. South Korea Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 85. Southeast Asia Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 86. India Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 87. Australia Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 88. China Taiwan Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 89. Europe Immunoisolation Cell Encapsulation Device Sales Market Share by Country in 2025
Figure 90. Europe Immunoisolation Cell Encapsulation Device Revenue Market Share by Country (2021-2026)
Figure 91. Europe Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Figure 92. Europe Immunoisolation Cell Encapsulation Device Sales Market Share by Application (2021-2026)
Figure 93. Germany Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 94. France Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 95. UK Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 96. Italy Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 97. Russia Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 98. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Market Share by Country (2021-2026)
Figure 99. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Figure 100. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Market Share by Application (2021-2026)
Figure 101. Egypt Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 102. South Africa Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 103. Israel Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 104. Turkey Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 105. GCC Countries Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 106. Manufacturing Cost Structure Analysis of Immunoisolation Cell Encapsulation Device in 2026
Figure 107. Manufacturing Process Analysis of Immunoisolation Cell Encapsulation Device
Figure 108. Industry Chain Structure of Immunoisolation Cell Encapsulation Device
Figure 109. Channels of Distribution
Figure 110. Global Immunoisolation Cell Encapsulation Device Sales Market Forecast by Region (2027-2032)
Figure 111. Global Immunoisolation Cell Encapsulation Device Revenue Market Share Forecast by Region (2027-2032)
Figure 112. Global Immunoisolation Cell Encapsulation Device Sales Market Share Forecast by Type (2027-2032)
Figure 113. Global Immunoisolation Cell Encapsulation Device Revenue Market Share Forecast by Type (2027-2032)
Figure 114. Global Immunoisolation Cell Encapsulation Device Sales Market Share Forecast by Application (2027-2032)
Figure 115. Global Immunoisolation Cell Encapsulation Device Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Immunoisolation Cell Encapsulation Device
Figure 2. Immunoisolation Cell Encapsulation Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunoisolation Cell Encapsulation Device Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Immunoisolation Cell Encapsulation Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Immunoisolation Cell Encapsulation Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Immunoisolation Cell Encapsulation Device Sales Market Share by Country/Region (2025)
Figure 10. Immunoisolation Cell Encapsulation Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Microcapsule Encapsulation Devices
Figure 12. Product Picture of Sheet and Pouch Macroencapsulation Devices
Figure 13. Product Picture of Hollow-Fiber Encapsulation Devices
Figure 14. Product Picture of Chamber Encapsulation Devices
Figure 15. Product Picture of Conformal Coating Encapsulation Devices
Figure 16. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Type in 2026
Figure 17. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Size-Selective Semipermeable Membrane
Figure 19. Product Picture of Hydrogel Matrix Barrier
Figure 20. Product Picture of Cellulose Sulfate Polymer Capsule
Figure 21. Product Picture of Local Immunomodulation Barrier
Figure 22. Product Picture of Nanoporous Membrane Barrier
Figure 23. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Immunoisolation Mechanism in 2026
Figure 24. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Immunoisolation Mechanism (2021-2026)
Figure 25. Product Picture of Human Donor Islets
Figure 26. Product Picture of Stem Cell-Derived Islet Cells
Figure 27. Product Picture of Porcine Islet Cells
Figure 28. Product Picture of Engineered Therapeutic Cells
Figure 29. Product Picture of Stem Cells and Stromal Cells
Figure 30. Product Picture of Other Therapeutic Cells
Figure 31. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Cell Source in 2026
Figure 32. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Cell Source (2021-2026)
Figure 33. Product Picture of Passive Diffusion Design
Figure 34. Product Picture of Prevascularized Design
Figure 35. Product Picture of Oxygen-Refueled Design
Figure 36. Product Picture of Oxygen-Generating Design
Figure 37. Product Picture of Port-Accessible Refillable Design
Figure 38. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Oxygenation and Vascularization Design in 2026
Figure 39. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Oxygenation and Vascularization Design (2021-2026)
Figure 40. Immunoisolation Cell Encapsulation Device Consumed in Type 1 Diabetes Cell Therapy
Figure 41. Global Immunoisolation Cell Encapsulation Device Market: Type 1 Diabetes Cell Therapy (2021-2026) & (Units)
Figure 42. Immunoisolation Cell Encapsulation Device Consumed in Metabolic and Endocrine Replacement
Figure 43. Global Immunoisolation Cell Encapsulation Device Market: Metabolic and Endocrine Replacement (2021-2026) & (Units)
Figure 44. Immunoisolation Cell Encapsulation Device Consumed in Protein and Enzyme Delivery
Figure 45. Global Immunoisolation Cell Encapsulation Device Market: Protein and Enzyme Delivery (2021-2026) & (Units)
Figure 46. Immunoisolation Cell Encapsulation Device Consumed in Cancer Local Cell Therapy
Figure 47. Global Immunoisolation Cell Encapsulation Device Market: Cancer Local Cell Therapy (2021-2026) & (Units)
Figure 48. Immunoisolation Cell Encapsulation Device Consumed in Cell Therapy R&D and Preclinical Evaluation
Figure 49. Global Immunoisolation Cell Encapsulation Device Market: Cell Therapy R&D and Preclinical Evaluation (2021-2026) & (Units)
Figure 50. Immunoisolation Cell Encapsulation Device Consumed in Bioreactor Cell Protection
Figure 51. Global Immunoisolation Cell Encapsulation Device Market: Bioreactor Cell Protection (2021-2026) & (Units)
Figure 52. Immunoisolation Cell Encapsulation Device Consumed in Other Applications
Figure 53. Global Immunoisolation Cell Encapsulation Device Market: Other Applications (2021-2026) & (Units)
Figure 54. Global Immunoisolation Cell Encapsulation Device Sale Market Share by Application (2025)
Figure 55. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Application in 2025
Figure 56. Immunoisolation Cell Encapsulation Device Sales by Company in 2025 (Units)
Figure 57. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Company in 2025
Figure 58. Immunoisolation Cell Encapsulation Device Revenue by Company in 2025 ($ millions)
Figure 59. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Company in 2025
Figure 60. Global Immunoisolation Cell Encapsulation Device Sales Market Share by Geographic Region (2021-2026)
Figure 61. Global Immunoisolation Cell Encapsulation Device Revenue Market Share by Geographic Region in 2025
Figure 62. Americas Immunoisolation Cell Encapsulation Device Sales 2021-2026 (Units)
Figure 63. Americas Immunoisolation Cell Encapsulation Device Revenue 2021-2026 ($ millions)
Figure 64. APAC Immunoisolation Cell Encapsulation Device Sales 2021-2026 (Units)
Figure 65. APAC Immunoisolation Cell Encapsulation Device Revenue 2021-2026 ($ millions)
Figure 66. Europe Immunoisolation Cell Encapsulation Device Sales 2021-2026 (Units)
Figure 67. Europe Immunoisolation Cell Encapsulation Device Revenue 2021-2026 ($ millions)
Figure 68. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales 2021-2026 (Units)
Figure 69. Middle East & Africa Immunoisolation Cell Encapsulation Device Revenue 2021-2026 ($ millions)
Figure 70. Americas Immunoisolation Cell Encapsulation Device Sales Market Share by Country in 2025
Figure 71. Americas Immunoisolation Cell Encapsulation Device Revenue Market Share by Country (2021-2026)
Figure 72. Americas Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Figure 73. Americas Immunoisolation Cell Encapsulation Device Sales Market Share by Application (2021-2026)
Figure 74. United States Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 75. Canada Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 76. Mexico Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 77. Brazil Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 78. APAC Immunoisolation Cell Encapsulation Device Sales Market Share by Region in 2025
Figure 79. APAC Immunoisolation Cell Encapsulation Device Revenue Market Share by Region (2021-2026)
Figure 80. APAC Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Figure 81. APAC Immunoisolation Cell Encapsulation Device Sales Market Share by Application (2021-2026)
Figure 82. China Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 83. Japan Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 84. South Korea Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 85. Southeast Asia Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 86. India Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 87. Australia Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 88. China Taiwan Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 89. Europe Immunoisolation Cell Encapsulation Device Sales Market Share by Country in 2025
Figure 90. Europe Immunoisolation Cell Encapsulation Device Revenue Market Share by Country (2021-2026)
Figure 91. Europe Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Figure 92. Europe Immunoisolation Cell Encapsulation Device Sales Market Share by Application (2021-2026)
Figure 93. Germany Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 94. France Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 95. UK Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 96. Italy Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 97. Russia Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 98. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Market Share by Country (2021-2026)
Figure 99. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Market Share by Type (2021-2026)
Figure 100. Middle East & Africa Immunoisolation Cell Encapsulation Device Sales Market Share by Application (2021-2026)
Figure 101. Egypt Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 102. South Africa Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 103. Israel Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 104. Turkey Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 105. GCC Countries Immunoisolation Cell Encapsulation Device Revenue Growth 2021-2026 ($ millions)
Figure 106. Manufacturing Cost Structure Analysis of Immunoisolation Cell Encapsulation Device in 2026
Figure 107. Manufacturing Process Analysis of Immunoisolation Cell Encapsulation Device
Figure 108. Industry Chain Structure of Immunoisolation Cell Encapsulation Device
Figure 109. Channels of Distribution
Figure 110. Global Immunoisolation Cell Encapsulation Device Sales Market Forecast by Region (2027-2032)
Figure 111. Global Immunoisolation Cell Encapsulation Device Revenue Market Share Forecast by Region (2027-2032)
Figure 112. Global Immunoisolation Cell Encapsulation Device Sales Market Share Forecast by Type (2027-2032)
Figure 113. Global Immunoisolation Cell Encapsulation Device Revenue Market Share Forecast by Type (2027-2032)
Figure 114. Global Immunoisolation Cell Encapsulation Device Sales Market Share Forecast by Application (2027-2032)
Figure 115. Global Immunoisolation Cell Encapsulation Device Revenue Market Share Forecast by Application (2027-2032)
